BGNE Snapshot
BeiGene, Ltd. discovers, develops, manufactures and markets cancer therapeutics drugs in the People's Republic of China and the United States. The company is headquartered in Beijing, the People's Republic of China.
Market Capitalization$32,977,631,000
Price to Sales31.04
Earnings per Share$-14.1700
PE RatioNone
Most Recent Close$343.2000
52 Week High$426.56
52 Week Low$219.2
50-Day Moving Average$367.8
200-Day Moving Average$336.18
All data are from Alpha Vantage as of today. For more infomation on BGNE see Stock Dividend, Valuation, Price and Financial Data for Investors